187 related articles for article (PubMed ID: 18021315)
1. Cell expression of GDAP1 in the nervous system and pathogenesis of Charcot-Marie-Tooth type 4A disease.
Pedrola L; Espert A; Valdés-Sánchez T; Sánchez-Piris M; Sirkowski EE; Scherer SS; Fariñas I; Palau F
J Cell Mol Med; 2008 Apr; 12(2):679-89. PubMed ID: 18021315
[TBL] [Abstract][Full Text] [Related]
2. GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria.
Pedrola L; Espert A; Wu X; Claramunt R; Shy ME; Palau F
Hum Mol Genet; 2005 Apr; 14(8):1087-94. PubMed ID: 15772096
[TBL] [Abstract][Full Text] [Related]
3. Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease.
Niemann A; Ruegg M; La Padula V; Schenone A; Suter U
J Cell Biol; 2005 Sep; 170(7):1067-78. PubMed ID: 16172208
[TBL] [Abstract][Full Text] [Related]
4. The Gdap1 knockout mouse mechanistically links redox control to Charcot-Marie-Tooth disease.
Niemann A; Huber N; Wagner KM; Somandin C; Horn M; Lebrun-Julien F; Angst B; Pereira JA; Halfter H; Welzl H; Feltri ML; Wrabetz L; Young P; Wessig C; Toyka KV; Suter U
Brain; 2014 Mar; 137(Pt 3):668-82. PubMed ID: 24480485
[TBL] [Abstract][Full Text] [Related]
5. Lack of GDAP1 induces neuronal calcium and mitochondrial defects in a knockout mouse model of charcot-marie-tooth neuropathy.
Barneo-Muñoz M; Juárez P; Civera-Tregón A; Yndriago L; Pla-Martin D; Zenker J; Cuevas-Martín C; Estela A; Sánchez-Aragó M; Forteza-Vila J; Cuezva JM; Chrast R; Palau F
PLoS Genet; 2015 Apr; 11(4):e1005115. PubMed ID: 25860513
[TBL] [Abstract][Full Text] [Related]
6. Charcot-Marie-Tooth disease-associated mutants of GDAP1 dissociate its roles in peroxisomal and mitochondrial fission.
Huber N; Guimaraes S; Schrader M; Suter U; Niemann A
EMBO Rep; 2013 Jun; 14(6):545-52. PubMed ID: 23628762
[TBL] [Abstract][Full Text] [Related]
7. A new missense GDAP1 mutation disturbing targeting to the mitochondrial membrane causes a severe form of AR-CMT2C disease.
Kabzińska D; Niemann A; Drac H; Huber N; Potulska-Chromik A; Hausmanowa-Petrusewicz I; Suter U; Kochański A
Neurogenetics; 2011 May; 12(2):145-53. PubMed ID: 21365284
[TBL] [Abstract][Full Text] [Related]
8. Charcot-Marie-Tooth-related gene GDAP1 complements cell cycle delay at G2/M phase in Saccharomyces cerevisiae fis1 gene-defective cells.
Estela A; Pla-Martín D; Sánchez-Piris M; Sesaki H; Palau F
J Biol Chem; 2011 Oct; 286(42):36777-86. PubMed ID: 21890626
[TBL] [Abstract][Full Text] [Related]
9. Charcot-Marie-Tooth disease CMT4A: GDAP1 increases cellular glutathione and the mitochondrial membrane potential.
Noack R; Frede S; Albrecht P; Henke N; Pfeiffer A; Knoll K; Dehmel T; Meyer Zu Hörste G; Stettner M; Kieseier BC; Summer H; Golz S; Kochanski A; Wiedau-Pazos M; Arnold S; Lewerenz J; Methner A
Hum Mol Genet; 2012 Jan; 21(1):150-62. PubMed ID: 21965300
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria and calcium defects correlate with axonal dysfunction in GDAP1-related Charcot-Marie-Tooth mouse model.
Civera-Tregón A; Domínguez L; Martínez-Valero P; Serrano C; Vallmitjana A; Benítez R; Hoenicka J; Satrústegui J; Palau F
Neurobiol Dis; 2021 May; 152():105300. PubMed ID: 33582224
[TBL] [Abstract][Full Text] [Related]
11. Dominant GDAP1 mutations cause predominantly mild CMT phenotypes.
Zimoń M; Baets J; Fabrizi GM; Jaakkola E; Kabzińska D; Pilch J; Schindler AB; Cornblath DR; Fischbeck KH; Auer-Grumbach M; Guelly C; Huber N; De Vriendt E; Timmerman V; Suter U; Hausmanowa-Petrusewicz I; Niemann A; Kochański A; De Jonghe P; Jordanova A
Neurology; 2011 Aug; 77(6):540-8. PubMed ID: 21753178
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dysfunction and pathophysiology of Charcot-Marie-Tooth disease involving GDAP1 mutations.
Cassereau J; Chevrollier A; Gueguen N; Desquiret V; Verny C; Nicolas G; Dubas F; Amati-Bonneau P; Reynier P; Bonneau D; Procaccio V
Exp Neurol; 2011 Jan; 227(1):31-41. PubMed ID: 20849849
[TBL] [Abstract][Full Text] [Related]
13. Calcium Deregulation and Mitochondrial Bioenergetics in GDAP1-Related CMT Disease.
González-Sánchez P; Satrústegui J; Palau F; Del Arco A
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669311
[TBL] [Abstract][Full Text] [Related]
14. Neuroinflammation in the pathogenesis of axonal Charcot-Marie-Tooth disease caused by lack of GDAP1.
Fernandez-Lizarbe S; Civera-Tregón A; Cantarero L; Herrer I; Juarez P; Hoenicka J; Palau F
Exp Neurol; 2019 Oct; 320():113004. PubMed ID: 31271761
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial complex I deficiency in GDAP1-related autosomal dominant Charcot-Marie-Tooth disease (CMT2K).
Cassereau J; Chevrollier A; Gueguen N; Malinge MC; Letournel F; Nicolas G; Richard L; Ferre M; Verny C; Dubas F; Procaccio V; Amati-Bonneau P; Bonneau D; Reynier P
Neurogenetics; 2009 Apr; 10(2):145-50. PubMed ID: 19089472
[TBL] [Abstract][Full Text] [Related]
16. Structural insights into Charcot-Marie-Tooth disease-linked mutations in human GDAP1.
Sutinen A; Nguyen GTT; Raasakka A; Muruganandam G; Loris R; Ylikallio E; Tyynismaa H; Bartesaghi L; Ruskamo S; Kursula P
FEBS Open Bio; 2022 Jul; 12(7):1306-1324. PubMed ID: 35509130
[TBL] [Abstract][Full Text] [Related]
17. A role for the GDAP1 gene in the molecular pathogenesis of Charcot‑Marie‑Tooth disease.
Rzepnikowska W; Kochański A
Acta Neurobiol Exp (Wars); 2018; 78(1):1-13. PubMed ID: 29694336
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial dynamics and inherited peripheral nerve diseases.
Pareyson D; Saveri P; Sagnelli A; Piscosquito G
Neurosci Lett; 2015 Jun; 596():66-77. PubMed ID: 25847151
[TBL] [Abstract][Full Text] [Related]
19. Clinical, electrophysiological and morphological findings of Charcot-Marie-Tooth neuropathy with vocal cord palsy and mutations in the GDAP1 gene.
Sevilla T; Cuesta A; Chumillas MJ; Mayordomo F; Pedrola L; Palau F; Vílchez JJ
Brain; 2003 Sep; 126(Pt 9):2023-33. PubMed ID: 12821518
[TBL] [Abstract][Full Text] [Related]
20. Similar clinical, pathological, and genetic features in Chinese patients with autosomal recessive and dominant Charcot-Marie-Tooth disease type 2K.
Fu J; Dai S; Lu Y; Wu R; Wang Z; Yuan Y; Lv H
Neuromuscul Disord; 2017 Aug; 27(8):760-765. PubMed ID: 28495047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
